Literature DB >> 30121141

Assessment of the timely administration of the hepatitis B and BCG birth dose and the primary infant vaccination schedule in 2015-2016 in the Mekong Delta, Viet Nam.

Tam Thi Pham1, Huu Minh Le1, Dat Tan Nguyen1, Kirsten Maertens2, Elke Leuridan3, Heidi Theeten3, Greet Hendrickx3, Pierre Van Damme3.   

Abstract

INTRODUCTION: Vietnam is implementing hepatitis B (HBV) birth dose (BD) vaccination since 2003 but coverage remains low, especially in the Mekong River Delta. This study aimed to determine the coverage of the HBV BD vaccination, to identify socio-demographic factors influencing HBV BD, and to assess reasons for non-immunization of neonates.
METHODS: A cross-sectional survey was conducted in 2015-2016. Mothers from 526 children aged 6-11 months living in 3 provinces in the Mekong River Delta - representing respectively urban, rural and remote area - were interviewed at home and infant vaccination documents were checked. The three-stage sampling method was adapted from WHO 30-cluster sampling. Predictors of HBV BD administration were identified with multiple regression analysis.
RESULTS: The overall HBV BD coverage (within 24 h) was 46.6% (compared to 44.5% for BCG) and was significantly higher in remote or rural than in urban area (OR 1.87 and 3.36, respectively), and in children whose father had a higher educational level (OR 2.76; 2.29 and 1.86, respectively, for master degree, bachelor and secondary school) as compared to a lower level. Main reasons for not having received HBV BD mentioned by parents were vaccines not offered by health care workers (53.0%), and illness of the infant (27.2%).
CONCLUSION: Although Vietnam started HBV BD vaccination more than 10 years ago, the coverage and timeliness need to improve to reach WHO targets (95% within 24 h after birth). Better training and information of health care workers, and better protocols ensuring timely HBV BD could address these vaccine administration thresholds.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30121141     DOI: 10.1016/j.vaccine.2018.08.002

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Validity and Reliability Assessment of Attitude Scales for Hepatitis B Vaccination Among Parents in Ho Chi Minh City, Vietnam.

Authors:  Giao Huynh; Duong Uyen Binh Pham; Truong Vien Nguyen; Vinh Quang Bui; Thi Ngoc Han Nguyen; Dang Dung Nguyen; Le An Pham
Journal:  Risk Manag Healthc Policy       Date:  2020-10-14

2.  Knowledge, attitudes and practices of hepatitis B prevention and immunization of pregnant women and mothers in northern Vietnam.

Authors:  Thi T Hang Pham; Thuy X Le; Dong T Nguyen; Chau M Luu; Bac D Truong; Phu D Tran; Mehlika Toy; Samuel So
Journal:  PLoS One       Date:  2019-04-10       Impact factor: 3.240

3.  Seroprevalence and factors associated with hepatitis B virus infection among the hill tribe youths, northern Thailand.

Authors:  Tawatchai Apidechkul
Journal:  BMC Infect Dis       Date:  2019-02-06       Impact factor: 3.090

4.  Hepatitis B Infection and Mother-to-Child Transmission in Haiphong, Vietnam: A Cohort Study with Implications for Interventions.

Authors:  Pham Minh Khue; Nguyen Thi Thuy Linh; Vu Hai Vinh; Luu Vu Dung; Bang Nguyen Van
Journal:  Biomed Res Int       Date:  2020-08-20       Impact factor: 3.411

5.  Assessment of the Timely Administration of Birth Dose Vaccines in Northern Nigeria and Associated Factors.

Authors:  Rasheedat Mobolaji Ibraheem; Bilkisu Ilah Garba; Rasaki Aliu; Olayinka Rasheed Ibrahim; Afeez Oyesola Bello; Salihu Sheni Mohammed; Mohammed Baba Abdulkadir; Rabiu Hashim; Lawal Magaji Ibrahim; Grace Ahmed
Journal:  Ann Glob Health       Date:  2022-07-26       Impact factor: 3.640

6.  Hepatitis B Birth Dose among Children in District 2 Hospital, Ho Chi Minh City, Vietnam: Prevalence and Associated Factors.

Authors:  Giao Huynh; Thanh Binh Nguyen; Ngoc Nga Cao; Minh Hoang Phan; Thi Bich Hop Dang; Thi Ngoc Han Nguyen
Journal:  Can J Infect Dis Med Microbiol       Date:  2020-07-15       Impact factor: 2.471

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.